Although cannabis is legal in nearly half of all U.S. states, policy is complicated. There's federal law, which prohibits the sale of THC-containing cannabis but not hemp. There's state law, which is an even more complex patchwork. In this episode: A new report looks at how this hazy landscape is impacting public health policy and equity.
Dr. Yasmin Hurd is a neuroscientist and the director of the Addiction Institute at the Icahn School of Medicine at Mount Sinai in New York.
Douglas Berman is a legal expert and the director of the Drug Enforcement Policy Center at the Moritz College of Lawat The Ohio State University.
Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department.
Cannabis Policy Impacts Public Health and Health Equity—National Academies of Science, Engineering, and Medicine
The Risks of Psychotic Symptoms With Cannabis Use in Younger People—Public Health On Call (January, 2024)
The Evidence—and Lack Thereof—About Cannabis—Public Health On Call (August, 2023)
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
